Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial.

Saved in:
Bibliographic Details
Title: Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial.
Authors: Hamaluba M; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Sang S; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Orindi B; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Njau I; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Karanja H; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Kamau N; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Gitonga JN; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Mugo D; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Wright D; Oxford Vaccine Group, University of Oxford, Oxford, England, UK., Nyagwange J; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Kutima B; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Omuoyo D; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Mwatasa M; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Ngetsa C; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Agoti C; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Cheruiyot S; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Nyaguara A; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Munene M; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Mturi N; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Oloo E; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Ochola-Oyier L; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Mumba N; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Mauncho C; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Namayi R; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Davies A; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.; Centre for Tropical Medicine & Global Health, University of Oxford, Oxford, England, UK., Tsofa B; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Nduati EW; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Aliyan N; Ministry of Health, Nairobi, Kenya., Kasera K; Ministry of Health, Nairobi, Kenya., Etyang A; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya., Boyd A; The Jenner Institute, University of Oxford, Oxford, England, UK., Hill A; The Jenner Institute, University of Oxford, Oxford, England, UK., Gilbert S; Pandemic Sciences Institute, University of Oxford, Oxford, England, UK., Douglas A; The Jenner Institute, University of Oxford, Oxford, England, UK., Pollard A; Oxford Vaccine Group, University of Oxford, Oxford, England, UK., Bejon P; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.; Centre for Tropical Medicine & Global Health, University of Oxford, Oxford, England, UK., Lambe T; Oxford Vaccine Group, University of Oxford, Oxford, England, UK.; Pandemic Sciences Institute, University of Oxford, Oxford, England, UK., Warimwe G; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.; Centre for Tropical Medicine & Global Health, University of Oxford, Oxford, England, UK.
Corporate Authors: COV004 Vaccine Trial Group
Source: Wellcome open research [Wellcome Open Res] 2023 Nov 27; Vol. 8, pp. 182. Date of Electronic Publication: 2023 Nov 27 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: Wellcome Trust Country of Publication: England NLM ID: 101696457 Publication Model: eCollection Cited Medium: Print ISSN: 2398-502X (Print) Linking ISSN: 2398502X NLM ISO Abbreviation: Wellcome Open Res Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38707489
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hamaluba+M%22">Hamaluba M</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Sang+S%22">Sang S</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Orindi+B%22">Orindi B</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Njau+I%22">Njau I</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Karanja+H%22">Karanja H</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Kamau+N%22">Kamau N</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Gitonga+JN%22">Gitonga JN</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Mugo+D%22">Mugo D</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Wright+D%22">Wright D</searchLink>; Oxford Vaccine Group, University of Oxford, Oxford, England, UK.<br /><searchLink fieldCode="AU" term="%22Nyagwange+J%22">Nyagwange J</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Kutima+B%22">Kutima B</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Omuoyo+D%22">Omuoyo D</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Mwatasa+M%22">Mwatasa M</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Ngetsa+C%22">Ngetsa C</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Agoti+C%22">Agoti C</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Cheruiyot+S%22">Cheruiyot S</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Nyaguara+A%22">Nyaguara A</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Munene+M%22">Munene M</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Mturi+N%22">Mturi N</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Oloo+E%22">Oloo E</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Ochola-Oyier+L%22">Ochola-Oyier L</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Mumba+N%22">Mumba N</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Mauncho+C%22">Mauncho C</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Namayi+R%22">Namayi R</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Davies+A%22">Davies A</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.; Centre for Tropical Medicine & Global Health, University of Oxford, Oxford, England, UK.<br /><searchLink fieldCode="AU" term="%22Tsofa+B%22">Tsofa B</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Nduati+EW%22">Nduati EW</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Aliyan+N%22">Aliyan N</searchLink>; Ministry of Health, Nairobi, Kenya.<br /><searchLink fieldCode="AU" term="%22Kasera+K%22">Kasera K</searchLink>; Ministry of Health, Nairobi, Kenya.<br /><searchLink fieldCode="AU" term="%22Etyang+A%22">Etyang A</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.<br /><searchLink fieldCode="AU" term="%22Boyd+A%22">Boyd A</searchLink>; The Jenner Institute, University of Oxford, Oxford, England, UK.<br /><searchLink fieldCode="AU" term="%22Hill+A%22">Hill A</searchLink>; The Jenner Institute, University of Oxford, Oxford, England, UK.<br /><searchLink fieldCode="AU" term="%22Gilbert+S%22">Gilbert S</searchLink>; Pandemic Sciences Institute, University of Oxford, Oxford, England, UK.<br /><searchLink fieldCode="AU" term="%22Douglas+A%22">Douglas A</searchLink>; The Jenner Institute, University of Oxford, Oxford, England, UK.<br /><searchLink fieldCode="AU" term="%22Pollard+A%22">Pollard A</searchLink>; Oxford Vaccine Group, University of Oxford, Oxford, England, UK.<br /><searchLink fieldCode="AU" term="%22Bejon+P%22">Bejon P</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.; Centre for Tropical Medicine & Global Health, University of Oxford, Oxford, England, UK.<br /><searchLink fieldCode="AU" term="%22Lambe+T%22">Lambe T</searchLink>; Oxford Vaccine Group, University of Oxford, Oxford, England, UK.; Pandemic Sciences Institute, University of Oxford, Oxford, England, UK.<br /><searchLink fieldCode="AU" term="%22Warimwe+G%22">Warimwe G</searchLink>; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.; Centre for Tropical Medicine & Global Health, University of Oxford, Oxford, England, UK.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22COV004+Vaccine+Trial+Group%22">COV004 Vaccine Trial Group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101696457%22">Wellcome open research</searchLink> [Wellcome Open Res] 2023 Nov 27; Vol. 8, pp. 182. <i>Date of Electronic Publication: </i>2023 Nov 27 (<i>Print Publication: </i>2023).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wellcome+Trust%22">Wellcome Trust </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101696457 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2398-502X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222398502X%22">2398502X </searchLink><i>NLM ISO Abbreviation: </i>Wellcome Open Res <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38707489
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.12688/wellcomeopenres.19150.2
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 182
    Titles:
      – TitleFull: Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hamaluba M
      – PersonEntity:
          Name:
            NameFull: Sang S
      – PersonEntity:
          Name:
            NameFull: Orindi B
      – PersonEntity:
          Name:
            NameFull: Njau I
      – PersonEntity:
          Name:
            NameFull: Karanja H
      – PersonEntity:
          Name:
            NameFull: Kamau N
      – PersonEntity:
          Name:
            NameFull: Gitonga JN
      – PersonEntity:
          Name:
            NameFull: Mugo D
      – PersonEntity:
          Name:
            NameFull: Wright D
      – PersonEntity:
          Name:
            NameFull: Nyagwange J
      – PersonEntity:
          Name:
            NameFull: Kutima B
      – PersonEntity:
          Name:
            NameFull: Omuoyo D
      – PersonEntity:
          Name:
            NameFull: Mwatasa M
      – PersonEntity:
          Name:
            NameFull: Ngetsa C
      – PersonEntity:
          Name:
            NameFull: Agoti C
      – PersonEntity:
          Name:
            NameFull: Cheruiyot S
      – PersonEntity:
          Name:
            NameFull: Nyaguara A
      – PersonEntity:
          Name:
            NameFull: Munene M
      – PersonEntity:
          Name:
            NameFull: Mturi N
      – PersonEntity:
          Name:
            NameFull: Oloo E
      – PersonEntity:
          Name:
            NameFull: Ochola-Oyier L
      – PersonEntity:
          Name:
            NameFull: Mumba N
      – PersonEntity:
          Name:
            NameFull: Mauncho C
      – PersonEntity:
          Name:
            NameFull: Namayi R
      – PersonEntity:
          Name:
            NameFull: Davies A
      – PersonEntity:
          Name:
            NameFull: Tsofa B
      – PersonEntity:
          Name:
            NameFull: Nduati EW
      – PersonEntity:
          Name:
            NameFull: Aliyan N
      – PersonEntity:
          Name:
            NameFull: Kasera K
      – PersonEntity:
          Name:
            NameFull: Etyang A
      – PersonEntity:
          Name:
            NameFull: Boyd A
      – PersonEntity:
          Name:
            NameFull: Hill A
      – PersonEntity:
          Name:
            NameFull: Gilbert S
      – PersonEntity:
          Name:
            NameFull: Douglas A
      – PersonEntity:
          Name:
            NameFull: Pollard A
      – PersonEntity:
          Name:
            NameFull: Bejon P
      – PersonEntity:
          Name:
            NameFull: Lambe T
      – PersonEntity:
          Name:
            NameFull: Warimwe G
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 27
              M: 11
              Text: 2023 Nov 27
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 2398-502X
          Numbering:
            – Type: volume
              Value: 8
          Titles:
            – TitleFull: Wellcome open research
              Type: main
ResultId 1